Immunomodulatory nonablative conditioning regimen for B-cell lymphoid malignancies.

Chinratanalab, Wichai; Reddy, Nishitha; Greer, John P; Morgan, David; Engelhardt, Brian; Kassim, Adetola; Brandt, Stephen J; Jagasia, Madan; Goodman, Stacey; Savani, Bipin N

Chinratanalab, Wichai; Reddy, Nishitha; Greer, John P; Morgan, David; Engelhardt, Brian; Kassim, Adetola; Brandt, Stephen J; Jagasia, Madan; Goodman, Stacey; Savani, Bipin N.

Affiliation

Chinratanalab W; Hematology and Stem Cell Transplantation Section, Division of Hematology/Oncology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA.

Exp Hematol ; 40(6): 431-5, 2012 Jun.

Article in En | MEDLINE | ID: mdl-22269114

Subject(s)

Hematopoietic Stem Cell Transplantation; Lymphoma, B-Cell/drug therapy; Transplantation Conditioning; Adult; Antigens, CD20/immunology; Antineoplastic Combined Chemotherapy Protocols/administration & dosage; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Female; Herpesvirus 4, Human/physiology; Humans; Lymphoma, B-Cell/immunology; Lymphoma, B-Cell/virology; Male; Middle Aged; Patient Readmission; Survival Analysis; Treatment Outcome; Virus Activation

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, B-Cell / Hematopoietic Stem Cell Transplantation / Transplantation Conditioning Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Exp Hematol Year: 2012 Document type: Article Affiliation country: United States Country of publication: Netherlands

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google